High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases.

Mohr M, Hartig I, Kessler T, Hamisch C, Kliesch S, Krug U, Spieker T, Semik M, Wiebe K, Pühse G, Hertle L, Liersch R, Müller-Tidow C, Mesters RM, Berdel WE (2012)
In: Bone Marrow Transplantation, 47(10)
Type of Publication: Research article (journal)

Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment.

Pühse G, Secker A, Kemper S, Hertle L, Kliesch S (2011)
In: International Journal of Andrology, 34(5 Pt 2)
Type of Publication: Research article (journal)

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.

Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A (2010)
In: Journal of Urology, 183(2)
Type of Publication: Research article (journal)

Long-term results of amitriptyline treatment for interstitial cystitis.

Hertle L, van Ophoven A (2010)
In: Aktuelle Urologie, 41 Suppl 1
Type of Publication: Research article (journal)

Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model.

Herrmann E, Tiemann A, Eltze E, Bolenz C, Bremer C, Persigehl T, Hertle L, Wülfing C (2009)
In: Journal of Cancer Research and Clinical Oncology, 135(10)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases. Mohr M, Hartig I, Kessler T, Hamisch C, Kliesch S, Krug U, Spieker T, Semik M, Wiebe K, Pühse G, Hertle L, Liersch R, Müller-Tidow C, Mesters RM, Berdel WE (2012) In: Bone Marrow Transplantation, 47(10) Type of Publication: Research article (journal)
Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib. Riesenbeck LM, Bierer S, Hoffmeister I, Köpke T, Papavassilis P, Hertle L, Thielen B, Herrmann E (2011) In: World Journal of Urology, 29(6) Type of Publication: Research article (journal)
Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. Pühse G, Secker A, Kemper S, Hertle L, Kliesch S (2011) In: International Journal of Andrology, 34(5 Pt 2) Type of Publication: Research article (journal)
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy. Bierer S, Hoffmeister I, Gerss J, Herrmann E, Wülfing C, Sibrowski W, Hertle L, Kelsch R (2011) In: Journal of Immunotherapy, 34(2) Type of Publication: Research article (journal)
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A (2010) In: Journal of Urology, 183(2) Type of Publication: Research article (journal)
Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss? Köpke T, Oberpenning F, Bettendorf O, Eltze E, Herrmann E, Hertle L, Weining C, Wulfing C, Semjonow A (2010) In: Anticancer Research, 30(5) Type of Publication: Research article (journal)
Long-term results of amitriptyline treatment for interstitial cystitis. Hertle L, van Ophoven A (2010) In: Aktuelle Urologie, 41 Suppl 1 Type of Publication: Research article (journal)
Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib. Herrmann E, Gerss J, Bierer S, Köpke T, Bolenz C, Hertle L, Wülfing C (2009) In: Journal of Cancer Research and Clinical Oncology, 135(1) Type of Publication: Research article (journal)
Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model. Herrmann E, Tiemann A, Eltze E, Bolenz C, Bremer C, Persigehl T, Hertle L, Wülfing C (2009) In: Journal of Cancer Research and Clinical Oncology, 135(10) Type of Publication: Research article (journal)
New therapeutic regimes in metastasic renal-cell carcinoma Bierer S, Hertle L, Nitschmann S (2008) In: Internist, 49(1) Type of Publication: Research article (journal)